View in EDS HTML Full Text PDF Full Text

Multicenter randomized, open-label phase II trial of sequential erlotinib and gemcitabine compared with gemcitabine monotherapy as first-line therapy in elderly or ECOG PS two patients with advanced NSCLC.

Saved in:

Bibliographic Details
Title:	Multicenter randomized, open-label phase II trial of sequential erlotinib and gemcitabine compared with gemcitabine monotherapy as first-line therapy in elderly or ECOG PS two patients with advanced NSCLC.
Authors:	Michael, Michael¹, White, Shane C², Abdi, Ehtesham^3,4, Nott, Louise⁵, Clingan, Phillip⁶, Zimet, Allan⁷, Button, Peter⁸, Gregory, Daniel⁹, Solomon, Benjamin¹⁰, Dobrovic, Alexander¹⁰, Do, Hongdo¹⁰, Clarke, Stephen¹¹
Source:	Asia Pacific Journal of Clinical Oncology. Mar2015, Vol. 11 Issue 1, p4-14. 11p.
Database:	Academic Search Ultimate
Full text is not displayed to guests. Login for full access.

Description
ISSN:	17437555
DOI:	10.1111/ajco.12178